Advanced search
Publication Cover
Renal Failure Volume 39, 2017 - Issue 1
Submit an article Journal homepage
2,413
Views
7
CrossRef citations to date
0
Altmetric
Clinical Study

Efficacy comparison of atorvastatin versus rosuvastatin on blood lipid and microinflammatory state in maintenance hemodialysis patients

Jianwei TianDivision of Nephrology, Nanfang Hospital, Southern Medical University, National Clinical Research Center of Kidney Disease, State Key Laboratory of Organ Failure Research, Guangdong Provincial Institute of Nephrology, Guangzhou, PR China; View further author information
,
Xiaoyan HouDivision of Nephrology, Nanfang Hospital, Southern Medical University, National Clinical Research Center of Kidney Disease, State Key Laboratory of Organ Failure Research, Guangdong Provincial Institute of Nephrology, Guangzhou, PR China; ;Division of Nephrology, the First Affiliated Hospital of Inner Mongolia Medical University, Hohhot, PR China; View further author information
,
Liping HuDivision of Nephrology, Nanfang Hospital, Southern Medical University, National Clinical Research Center of Kidney Disease, State Key Laboratory of Organ Failure Research, Guangdong Provincial Institute of Nephrology, Guangzhou, PR China; View further author information
,
Ting ChenDivision of Nephrology, Nanfang Hospital, Southern Medical University, National Clinical Research Center of Kidney Disease, State Key Laboratory of Organ Failure Research, Guangdong Provincial Institute of Nephrology, Guangzhou, PR China; View further author information
,
Kefei WuDepartment of Nephrology, the First Affiliated Hospital, Shantou Medical University, Shantou, PR ChinaView further author information
,
Chudan CaiDepartment of Nephrology, the First Affiliated Hospital, Shantou Medical University, Shantou, PR ChinaView further author information
&
Xiaoyan BaiDivision of Nephrology, Nanfang Hospital, Southern Medical University, National Clinical Research Center of Kidney Disease, State Key Laboratory of Organ Failure Research, Guangdong Provincial Institute of Nephrology, Guangzhou, PR China; Correspondence[email protected], [email protected]
View further author information
 show all
Pages 153-158 | Received 12 Jun 2016, Accepted 27 Oct 2016, Published online: 15 Nov 2016

References

  • Chiu YW, Jiwakanon S, Lukowsky L, Duong U, Kalantar-Zadeh K, Mehrotra R. An update on the comparisons of mortality outcomes of hemodialysis and peritoneal dialysis patients. Semin Nephrol. 2011;31:152–158.
  • Silva LS, Oliveira RA, Silva GB, et al. Cardiovascular disease in patients with end-stage renal disease on hemodialysis in a developing country. Saudi J Kidney Dis Transplant. 2012;23:262–266.
  • Ren H, Zhou X, Luan Z, et al. The relationship between carotid atherosclerosis, inflammatory cytokines, and oxidative stress in middle-aged and elderly hemodialysis patients. Int J Nephrol. 2013;2013:835465.
  • Drew DA, Bhadelia R, Tighiouart H, et al. Anatomic brain disease in hemodialysis patients: A cross-sectional study. Am J Kidney Dis. 2013;61:271–278.
  • Sanchez-Aguilar M, Tapia-Perez JH, Sanchez-Rodriguez JJ, et al. Effect of rosuvastatin on cytokines after traumatic head injury. J Neurosurg. 2013;118:669–675.
  • Mikolasevic I, Lukenda V, Racki S, Milic S, Sladoje-Martinovic B, Orlic L. Nonalcoholic fatty liver disease (NAFLD) – A new factor that interplays between inflammation, malnutrition, and atherosclerosis in elderly hemodialysis patients. Clin Intervent Aging. 2014;9:1295–1303.
  • Rahimi-Ardabili B, Argani H, Ghorbanihaghjo A, et al. Paraoxonase enzyme activity is enhanced by zinc supplementation in hemodialysis patients. Renal Failure. 2012;34:1123–1128.
  • Shi L, Song J, Zhang X, Li Y, Li H. Correlation between the microinflammatory state and left ventricular structural and functional changes in maintenance haemodialysis patients. Exp Ther Med. 2013;6:532–536.
  • Pouresmaeil R, Razeghi E, Ahmadi F. Correlation of serum lead levels with inflammation, nutritional status, and clinical complications in hemodialysis patients. Renal Failure. 2012;34:1114–1117.
  • Zyga S, Christopoulou G, Malliarou M. Malnutrition-inflammation-atherosclerosis syndrome in patients with end-stage renal disease. J Renal Care. 2011;37:12–15.
  • Dashti N, Einollahi N, Nabatchian F, Moradi Sarabi M, Zarebavani M. Significance of albumin and C-reactive protein variations in 300 end stage renal disease patients in Tehran University of Medical Sciences Hospitals during year 2010. Acta Med Iran. 2012;50:197–202.
  • Memoli B, Salerno S, Procino A, et al. A translational approach to micro-inflammation in end-stage renal disease: Molecular effects of low levels of interleukin-6. Clin Sci. 2010;119:163–174.
  • Inoue T, Komoda H, Nonaka M, Kameda M, Uchida T, Node K. Interleukin-8 as an independent predictor of long-term clinical outcome in patients with coronary artery disease. Int J Cardiol. 2008;124:319–325.
  • Ballantyne CM, Pitt B, Loscalzo J, Cain VA, Raichlen JS. Alteration of relation of atherogenic lipoprotein cholesterol to apolipoprotein B by intensive statin therapy in patients with acute coronary syndrome (from the Limiting UNdertreatment of lipids in ACS With Rosuvastatin [LUNAR] Trial). Am J Cardiol. 2013;111:506–509.
  • Wassmann S, Faul A, Hennen B, Scheller B, Bohm M, Nickenig G. Rapid effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition on coronary endothelial function. Circ Res. 2003;93:e98–103.
  • Luvai A, Mbagaya W, Hall AS, Barth JH. Rosuvastatin: A review of the pharmacology and clinical effectiveness in cardiovascular disease. Clin Med Insights Cardiol. 2012;6:17–33.
  • Liu Y, Liu YH, Tan N, Chen JY, Zhou YL, Li LW, et al. Comparison of the efficacy of rosuvastatin versus atorvastatin in preventing contrast induced nephropathy in patient with chronic kidney disease undergoing percutaneous coronary intervention. PLoS One. 2014;9:e111124.
  • Ferreira TS, Lanzetti M, Barroso MV, et al. Oxidative stress and inflammation are differentially affected by atorvastatin, pravastatin, rosuvastatin, and simvastatin on lungs from mice exposed to cigarette smoke. Inflammation. 2014;37:1355–1365.
  • Kurtoglu E, Balta S, Sincer I, et al. Comparison of effects of rosuvastatin versus atorvastatin treatment on plasma levels of asymmetric dimethylarginine in patients with hyperlipidemia having coronary artery disease. Angiology. 2014;65:788–793.
  • Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63:2889–2934.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.